Queen Elizabeth Hospital in King's Lynn, Norfolk, England. It is located on the outskirts of King's Lynn, to the eastern edge of the town.

There are 515 beds in Queen Elizabeth Hospital.

During the past decade, Queen Elizabeth Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "Lymphoma Trials Office" with 3 trials sponsored, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials sponsored and "University College, London" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 collaborator was "King's College London" with 2 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator, "Addenbrookes Charitable Trust" with 1 trials as a collaborator, "Barts and the London School of Medicine and Dentistry" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital" are "Breast Cancer" (5 trials), "Lymphoma" (5 trials), "Lung Cancer" (3 trials), "Breast Cancer Female" (2 trials) and "Critical Illness" (2 trials). Many other conditions were trialed in "Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital" are "Drug" (23 trials), "Other" (8 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "Placebo" (4 trials), "adjuvant therapy" (3 trials), "epirubicin hydrochloride" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital" are 31 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queen Elizabeth Hospital". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Queen Elizabeth Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".